Surefuser™+ makes it possible for patients to remain at home in familiar surroundings even during severe phases of their illness.When the balloon reservoir is filled with a liquid medicinal product, the reservoir (which is made of latex-free isoprene rubber) expands. (PDF/393 KB) (PDF/92.84 KB)
(PDF/67.55 KB) (PDF/86.9 KB) medac Gesellschaft für klinische Spezialpräparate mbH
MG 33 000 D).Urokinase belongs to the group of direct plasminogen activators. (PDF/50.03 KB) Maintenance: 20 mg daily. (PDF/87.73 KB) (PDF/63.43 KB) maladie altérant les défenses immunitaires (par exemple patient atteint du Fréquents (1 à 10% des patients) : diarrhées, nausées, vomissements, aphtes, douleurs abdominales, Peu fréquents (moins de 1 patient sur 100) : perturbation du goût, anxiété, rupture de tendons, Une augmentation de la fréquence des infections peut également survenir.
(PDF/35.5 KB) Une contraception efficace est indispensable. Typical maintenance dosage: 20 mg … LT - Paciento priminimo kortelė The effect of treosulfan is due to its spontaneous conversion into a mono epoxide intermediate and L-diepoxybutane under physiological conditions (pH 7.4; temperature 37° C).The epoxides formed alkylate the nucleophilic centres of deoxyribonucleic acid (DNA) and are able to induce DNA crosslinks, which are thought to be responsible for the stem cell degrading and antineoplastic activity.1 tablet contains 30 mg trospium chloride. The recommended maintenance dose is 10 to 20 mg once a day in patients with rheumatoid arthritis, and 20 mg once a day in patients with psoriatic arthritis. By accumulating on the bone surface it inhibits the mineralisation of bone substance, while checking bone decomposition by inhibiting the osteoclasts. Leflunomide at a daily dose of at least 10 mg (10 to 25 mg in study YU203, 20 mg in studies MN301 and US301) was statistically significantly superior to placebo in reducing the signs and symptoms of rheumatoid arthritis in all 3 placebo-controlled trials. (PDF/44.33 KB) (PDF/81.28 KB) Adult Initially, loading dose: 100 mg daily for 3 days.
(PDF/65.21 KB)
Vous trouverez une description de chacun des objectifs sur la façon dont nos partenaires et nous-mêmes utilisons vos données personnelles.Un composé issu du léflunomide persiste très longtemps dans le sang (plusieurs mois, voire années) ; des Des analyses sanguines régulières sont prescrites par le médecin. This is called a loading dose.
(PDF/91.29 KB) Trial 2 randomized 358 patients with active RA to leflunomide 20 mg/day (n=133), sulfasalazine 2.0 g/day (n=133), or placebo (n=92). (PDF/105.97 KB) (PDF/90.25 KB) (PDF/88.7 KB) (PDF/433.19 KB) It is an antineoplastic agent which acts by promoting the assembly of tubulin into stable microtubules and inhibits their disassembly which leads to a marked decrease of free tubulin. The website cannot function properly without these cookies.These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. (PDF/290.99 KB) Docetaxel disrupts the microtubular network in cells which is essential for vital mitotic and interphase cellular functions.Paclitaxel stabilises the microtubules of the mitosis spindles in cells that are dividing. (PDF/87.71 KB)
Urokinase 500 000 HS medac Zoledronic acid medac 4 mg/100 ml solution for infusion (PDF/290.99 KB) (PDF/40.62 KB)
(PDF/80.44 KB)
(PDF/34.78 KB) EE - Patsiendi meeldetuletuskaart
FI - Potilaan muistutuskortti (PDF/133.55 KB) FI - Swedish translation: Påminnelsekort för patienter (PDF/499.25 KB) Taxceus 20 mg/ml concentrate for solution for infusion
Vous pouvez configurer vos réglages et choisir comment vous souhaitez que vos données personnelles soient utilisées en fonction des objectifs ci-dessous.
The elimination half-life is approx. Package size: 100 capsulesHydroxycarbamide mainly acts by inhibiting the enzyme ribonucleotide reductase. (PDF/44.48 KB) (PDF/68.3 KB) (PDF/106.66 KB) (PDF/516.13 KB) (PDF/335.73 KB)
(PDF/105.24 KB) (PDF/104.71 KB)
EMA is in the process of making appropriate changes to this website. (PDF/68.35 KB)